Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current developments of immunotherapy in the clinic.

Scott Antonia1, James J Mulé, Jeffrey S Weber

  • 1H. Lee Moffitt Comprehensive Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, Florida 33612, USA.

Current Opinion in Immunology
|March 17, 2004
PubMed
Summary

Cancer immunotherapy, including T-cell transfer and vaccines, is advancing. New strategies aim to improve efficacy by overcoming tumor tolerance and enhancing immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

iNOS is a key mediator of anti-PD-1 melanoma therapy response.

Frontiers in immunology·2026
Same author

Alirocumab Plus Cemiplimab in Immunorefractory NSCLC: A Single Arm Phase 2 Study.

Research square·2026
Same author

Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade.

Cell·2026
Same author

Strengthening Antisense Oligonucleotide-Mediated Anti-Tumor Immunity via Metal-Organic Framework Nanoparticles.

Nano letters·2026
Same author

The Myeloid Biomarker <i>MS4A6A</i> Drives an Immunosuppressive Microenvironment in Glioblastoma via Activation of the PGE2 Signaling Axis.

International journal of molecular sciences·2026
Same author

Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Cancer immunotherapy is a rapidly evolving field.
  • Current approaches include adoptive T-cell transfer and therapeutic vaccines.
  • Recent advancements show improved clinical and immunological outcomes.

Purpose of the Study:

  • To explore novel strategies for enhancing cancer immunotherapy efficacy.
  • To investigate methods for overcoming tumor tolerance.
  • To identify ways to boost anti-tumor immune responses.

Main Methods:

  • Developing novel strategies in preclinical models.
  • Translating laboratory findings into clinical applications.
  • Employing techniques to inhibit regulatory cells and break tolerance to tumor self-antigens.

Related Experiment Videos

  • Utilizing T-cell co-stimulation and combinations of recombinant cytokines.

    • Main Results:

    • Improved clinical and immunological endpoints observed.
    • Novel strategies are transitioning from preclinical studies to clinical trials.
    • Methods focus on enhancing the body's immune response against cancer.

    Conclusions:

    • Advancements in immunotherapy are improving cancer treatment.
    • Novel strategies hold promise for enhancing therapeutic efficacy.
    • Targeting immune tolerance and enhancing immune activity are key to future success.